Okay, let's tackle this question. The question is about which type of cardiomyopathy is caused by amyloidosis. First, I need to recall the different types of cardiomyopathies and their causes. Amyloidosis is a condition where abnormal proteins called amyloids build up in tissues and organs. In the heart, this would lead to structural changes.

I remember that there are several types of cardiomyopathy: dilated, hypertrophic, restrictive, and arrhythmogenic right ventricular. Amyloidosis is known to affect the heart's structure, making it stiff. Restrictive cardiomyopathy is characterized by a stiff heart muscle that doesn't relax properly, preventing the heart from filling with enough blood. That sounds like what happens in amyloidosis because the amyloid deposits make the heart walls rigid.

Wait, let me confirm. Hypertrophic cardiomyopathy is usually due to thickened heart muscle, often genetic. Dilated is when the chambers are enlarged. Restrictive is the stiffness. So amyloidosis would fall under restrictive. But sometimes, people might confuse it with hypertrophic if they're not careful. Also, restrictive cardiomyopathy can have other causes like sarcoidosis or hemochromatosis. But amyloid is a classic cause.

The options aren't listed, but the correct answer is restrictive. So the explanation should highlight that amyloid deposits in the myocardium lead to restrictive cardiomyopathy by impairing diastolic filling. The other options like hypertrophic or dilated are incorrect because they involve different pathologies. The clinical pearl is to remember that restrictive cardiomyopathy is often due to infiltrative diseases like amyloidosis.

**Core Concept**
Amyloidosis is an infiltrative disorder where misfolded proteins (amyloid fibrils) deposit in tissues, including the myocardium. This leads to **restrictive cardiomyopathy** due to impaired diastolic filling caused by myocardial stiffness. Key diagnostic features include echocardiographic evidence of a "granular" myocardium and biopsy confirmation of amyloid deposits.

**Why the Correct Answer is Right**
Amyloid deposits in the myocardium replace normal cardiac tissue, increasing myocardial rigidity. This impairs ventricular filling during diastole, resulting in restrictive physiology (elevated filling pressures, reduced compliance). Histologically, Congo red staining under polarized light reveals apple-green birefringence, confirming amyloidosis. Unlike hypertrophic cardiomyopathy, there is no myocyte hypertrophy; instead, the heart appears "stiff" with normal or reduced chamber size.

**Why Each Wrong Option is Incorrect**
**Option A:** *Dilated cardiomyopathy* involves chamber dilation and systolic dysfunction, not stiffness.
**Option B:** *Hypertrophic cardiomyopathy* is caused by sarcomeric mutations leading to asymmetric septal hypertrophy, not amyloid infiltration.
**Option C:** *Arrhythmogenic right ventricular cardiomyopathy* involves fatty infiltration of the right ventricle, unrelated to amyloidosis.

**Clinical Pearl / High-Yield Fact**
Remember the "3 R's" of restrictive cardiomyopathy: **Restrictive** physiology, **Rigid** myocardium (from infiltrates like amyloid or iron), and **Reduced** diastolic function. Amyloidosis is a **classic infiltrative cause**, often presenting

✓ Correct Answer: B. Restrictive